Doug Manion: CEO of Kleo Pharmaceuticals

"I think I've always found motivation from being able to take a highly technical topic and dig in. I'm never the person that knows most about the topic. But I strive to be like the person who knows th...

10 Heinä 202139min

Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheime...

30 Touko 202131min

Lanny Sun, co-founder of Silicon Therapeutics, recently acquired by Roivant Sciences. speaks with corporate branding veteran John Simboli about leadership in biopharma. Lanny also discusses how Silico...

1 Touko 202137min

Joan Perelló, co-founder and CEO of Sanifit, shares his thoughts with BioBoss host John Simboli about leadership and how Sanifit is pursuing the development of treatments for progressive vascular calc...

3 Huhti 202137min

Saiid Zarrabian, President and CEO of Kintara Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and how Kintara is pursuing the development of new cancer therapies for ...

13 Maalis 202127min

John Temperato, President and Chief Executive Officer of 9 Meters Biopharma, speaks with BioBoss host John Simboli about leadership in biopharma and how 9 Meters is advancing drug candidates for patie...

7 Helmi 202132min

Shawn Singh, CEO of VistaGen, speaks with BioBoss host John Simboli about leadership and VistaGen's working to develop a new generation of medications for anxiety, depression and other central nervous...

10 Tammi 202140min

BioBoss podcast host John Simboli reflects on the success of seasons 1 and 2 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss seas...

6 Tammi 20211min